Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED study
Europace · 01.11.2024 · 26 (11)
DOI: 10.1093/europace/euae273 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Europace, online erschienen am 01.11.2024. Verfasst von Mikhael F El-Chami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Emory University School of Medicine, 100 Woodruff Circle, 550 Peachtree Street NE, Atlanta, GA 30308,…. Hauptthemen laut MEDLINE: Bradycardia, Pacemaker, Artificial. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic Inc..
Abstract (Originalsprache)
Aims
Leadless pacing is a safe and effective alternative to transvenous pacing for bradycardia. Micra AV is a leadless, single-device solution that provides atrioventricular synchronous ventricular pacing therapy. Early results from the Micra AV CED study showed reductions in short-term complications associated with the Micra AV leadless pacemaker among US Medicare patients. The objective of this study is to compare chronic complications, re-interventions, and all-cause mortality at 2 years between patients implanted with a Micra AV leadless pacemaker and a traditional dual-chamber transvenous (DC-TV) pacemaker. Methods and results Patients implanted with a Micra AV leadless pacemaker (n = 7552) or a DC-TV pacemaker (n = 110 558) in 2020 and 2021 were identified using device registration-linked Medicare administrative claims data. Competing risk models compared the unadjusted and propensity score overlap weight–adjusted complication, re-intervention, and all-cause mortality rates of Micra AV and DC-TV patients at 2 years. Micra AV patients had significantly more comorbidities (end-stage renal disease 14.9 vs. 2.0%, P < 0.0001; renal dysfunction 47.9 vs. 34.2%, P < 0.0001; diabetes 46.2 vs. 38.3%, P < 0.001; congestive heart failure 41.4 vs. 30.6%, P < 0.0001). Two years post-implant, Micra AV patients had lower complication rates [adjusted 5.3 vs. 9.6%, hazard ratio (HR): 0.54, 95% confidence interval (CI) 0.49–0.61, P < 0.0001] and lower re-intervention rates (adjusted 3.5 vs. 5.6%, HR: 0.62, 95% CI 0.54–0.72, P < 0.0001) than DC-TV patients. Upgrades to cardiac resynchronization therapy were low in both groups (adjusted 1.6 vs. 1.7%, P = 0.40), as were Micra AV upgrades to a dual-chamber system (adjusted 1.4%). All-cause mortality rates remained higher in Micra AV than in DC-TV patients (unadjusted HR: 2.48, 95% CI 2.35–2.62, P < 0.0001; adjusted HR: 1.53, 95% CI 1.44–1.62, P < 0.0001).
Conclusion
Patients implanted with Micra AV had lower complications and re-intervention rates at 2 years than patients implanted with a traditional DC-TV pacemaker. All-cause mortality remained higher in Micra AV patients, likely due to their higher comorbidity burden and other differences in baseline characteristics. Clinical trial registration ClinicalTrials.gov ID NCT04235491
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, Emory University School of Medicine, 100 Woodruff Circle, 550 Peachtree Street NE, Atlanta, GA 30308, USA.
- Medtronic, Inc., Minneapolis, MN, USA.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
ORCID-Profile: Mikhael F El-Chami, Lucas Higuera, Colleen Longacre, Kurt Stromberg, George Crossley, Jonathan P Piccini
Förderung
- Medtronic Inc.
Zitieren
APA
El-Chami, M. F., Higuera, L., Longacre, C., Stromberg, K., Crossley, G., & Piccini, J. P. (2024). Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED study. Europace, 26(11). https://doi.org/10.1093/europace/euae273
Vancouver
El-Chami MF, Higuera L, Longacre C, Stromberg K, Crossley G, Piccini JP. Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED study. Europace. 2024;26(11). doi:10.1093/europace/euae273
BibTeX
@article{ElChami2024,
author = {El-Chami, Mikhael F and Higuera, Lucas and Longacre, Colleen and Stromberg, Kurt and Crossley, George and Piccini, Jonathan P},
title = {Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED study},
journal = {Europace},
year = {2024},
volume = {26},
number = {11},
doi = {10.1093/europace/euae273}
}
EUVIMED